Competing Risk of Ventricular Tachyarrhythmia and Nonarrhythmic Mortality in Advanced Heart Failure
JACC: Clinical Electrophysiology · 2026-08 · 12 (8) · 1996-2006
DOI: 10.1016/j.jacep.2026.02.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026-08. Verfasst von Alon Barsheshet und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rabin Medical Center, Petah-Tikva and The Gray Faculty of Medical and Health sciences, Tel Aviv University, Tel Aviv, Israe…. Hauptthemen laut MEDLINE: Stroke Volume, Heart Failure, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Patients with heart failure and reduced left ventricular ejection fraction (LVEF) are at elevated risk of ventricular tachycardia or fibrillation (VT/VF), pump failure, and noncardiac death. OBJECTIVES: The purpose of this study was to evaluate the relationship between LVEF and VT/VF risk, accounting for nonarrhythmic mortality as a competing event. METHODS: We analyzed primary prevention implantable cardioverter-defibrillator (ICD) recipients from 5 major trials (MADIT-II [Multicenter Automatic Defibrillator Implantation Trial II], MADIT-CRT [Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy], MADIT-RIT [Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy], MADIT-RISK, RAID [Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillator]), stratified by LVEF tertiles (≤20%, 21%-29%, 30%-35%). Outcomes included sustained VT/VF (primary), fast VT/VF (≥200 beats/min), appropriate ICD shocks, and all-cause mortality. Fine and Gray models were used to adjust for the competing risk of nonarrhythmic mortality. RESULTS: The study population comprised 5,168 patients. At 3 years, the cumulative incidence of sustained VT/VF was inversely correlated with increasing LVEF tertiles: 28% for LVEF ≤20%, 23% for LVEF 21%-29%, and 20% for LVEF 30%-35% (P 20%. These associations were similar across subgroups, cardiac resynchronization therapy-defibrillator use, and cardiomyopathy etiology. Patients with LVEF ≤20% also had a 1.5-fold increased risk of all-cause mortality (P < 0.001). CONCLUSIONS: Patients with very low LVEF have higher cumulative incidence of sustained VT/VF and ICD shocks, along with an increased competing risk of death. These findings suggest that LVEF is an important factor in the shared decision-making process for a primary prevention ICD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Rabin Medical Center, Petah-Tikva and The Gray Faculty of Medical and Health sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: barshesheta@gmail.com.
- Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Cardiology, Rabin Medical Center, Petah-Tikva and The Gray Faculty of Medical and Health sciences, Tel Aviv University, Tel Aviv, Israel.
Zitieren
APA
Barsheshet, A., Goldenberg, I., Gelikas, S., McNitt, S., Polonsky, B., Erez, A., Goldenberg, G., Kumets, I., Tal, S., Aktas, M., Zareba, W., & Golovchiner, G. (2026). Competing Risk of Ventricular Tachyarrhythmia and Nonarrhythmic Mortality in Advanced Heart Failure. JACC: Clinical Electrophysiology, 12(8), 1996-2006. https://doi.org/10.1016/j.jacep.2026.02.028
Vancouver
Barsheshet A, Goldenberg I, Gelikas S, McNitt S, Polonsky B, Erez A, et al. Competing Risk of Ventricular Tachyarrhythmia and Nonarrhythmic Mortality in Advanced Heart Failure. JACC: Clinical Electrophysiology. 2026;12(8):1996-2006. doi:10.1016/j.jacep.2026.02.028
BibTeX
@article{Barsheshet2026,
author = {Barsheshet, Alon and Goldenberg, Ilan and Gelikas, Shaul and McNitt, Scott and Polonsky, Bronislava and Erez, Aharon and Goldenberg, Gustavo and Kumets, Ilya and Tal, Shir and Aktas, Mehmet and Zareba, Wojciech and Golovchiner, Gregory},
title = {Competing Risk of Ventricular Tachyarrhythmia and Nonarrhythmic Mortality in Advanced Heart Failure},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
volume = {12},
number = {8},
pages = {1996--2006},
doi = {10.1016/j.jacep.2026.02.028}
}
EUVIMED